Drug development can be an expensive and tedious process. Add in the urgency of the COVID-19 pandemic, and you have a recipe for frustration. Biosimulation -- using computers to simulate drug response in humans -- can help accelerate the process, which Certara hopes to achieve with a new platform launched today targeted at COVID-19 vaccine development. Discuss
Bristol Myers Squibb has paid $12 million to Dragonfly Therapeutics to license a fourth immunotherapy drug candidate from Dragonfly's TrinKet portfolio.
A new technology platform using self-assembling peptide nanofibers tagged with antibodies can be an effective SARS-CoV-2 vaccine, according to a proof-of-concept study published in Science Advances on August 7. Discuss
Novavax and Takeda Pharmaceutical have formed a partnership for the development, manufacturing, and commercialization in Japan of NVX-CoV2373, Novavax's COVID-19 vaccine candidate.
Contract research organizations (CROs) Caprion-HistoGeneX and Viroclinics have formed a strategic partnership to develop therapeutics and prophylactic solutions targeting infectious diseases like COVID-19.
Precigen is highlighting clinical results from a phase I trial conducted by its subsidiary Precigen Triple-Gene that show that its multigenic investigational therapeutic agent for heart failure improves patient outcomes.
Cellect Biotechnology has secured a European patent for its stem cell selection technology. The patent was also approved in Australia and Israel, according to the firm.
Amazon Web Services is providing cloud, analytics, and machine-learning services to Moderna for its messenger RNA platform and manufacturing facility.
Could vaccine platforms developed for previous coronaviruses be converted to address the current COVID-19 pandemic? An August 5 report in Nature described how researchers leveraged previous vaccine research to develop mRNA-1273, a new SARS-CoV-2 vaccine candidate. Discuss
Kriya Therapeutics has secured a 51,000-sq-ft facility in Research Triangle Park, NC, to establish internal operational manufacturing of its pipeline of adeno-associated virus-based gene therapies.
Conferences
ACS Fall 2020 Virtual Meeting & Expo
August 17-20
August 17-20
ESMO Virtual Congress 2020
September 14-29
September 14-29
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
|
General Discussion
|
||
| Topic | Replies / Views | Last Update |
|---|---|---|
|
Childhood vaccines may help protect against COVID-19 mortality
|
0 / 6 | More than 3 days ago |
|
https://academic.oup.com/ve/pages/coronavirus-evolution
|
0 / 49 | More than 3 days ago |
|
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
|
0 / 14 | More than 3 days ago |
|
Engineered Bacteria Produces BeeFree Honey
|
0 / 13 | More than 3 days ago |
|
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
|
0 / 15 | More than 3 days ago |
| To see more posts from our community or to share a post of your own, go to our community's forum page. | ||
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
